FindTrial
Sign In

Pathological classification of lacrimal gland lesions and the role of APRIL in lacrimal gland of of IgG4-related ophthalmopathy

Pathological classification of lacrimal gland lesions and the role of APRIL in lacrimal gland of of IgG4-related ophthalmopathy

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2300069492
Enrollment
Unknown
Registered
2023-03-19
Start date
2023-03-20
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

lacrimal gland lesions

Interventions

IgG4-ROD group:N/A
lymphoproliferative lesions of non-IgG4-ROD group:N/A

Sponsors

West China Hospital of Sichuan University
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Patients undergoing incisional or excisional lacrimal gland biopsy from January 2010 to December 2021 in West China Hospital of Sichuan University in China; 2. The lacrimal gland specimens of IgG4-ROD and lymphoproliferative lesions of non-IgG4-ROD (control group) pathologically diagnosed in West China Hospital of Sichuan University.

Exclusion criteria

Exclusion criteria: Patients which consulted for pathological diagnosis and duplicated were excluded.

Design outcomes

Primary

MeasureTime frame
Basic information of patients, clinical manifestations, serological examination, imaging results, pathological diagnosis, CD 138, CD20, April-8;—

Countries

China

Contacts

Public ContactHe Weimin

West China Hospital of Sichuan University

hewm888@hotmail.com+86 18980601753

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026